Get started
Author

Abigail Seward

Observed name: A Seward
ORCID: 0009-0004-6685-185X
Observed ORCID: 0009-0004-6685-185X
OpenAlex ID: A5113026557
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 566
PDF
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
2024 · Nurulamin M Noor, James C Lee, et al. · The Lancet. Gastroenterology & hepatology · 354
PDF
Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort study
2025 · Shankar Kumar, Andrew Plumb, et al. · Health Technology Assessment · 2
OP01 PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s disease
2024 · N Noor, J Lee, et al. · Journal of Crohn s and Colitis · 2
PDF
O27 BMJ Open Gastroenterology best clinical science abstract: endoscopic outcomes from PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s disease
2024 · Nuru Noor, James Lee, et al. · Gut
986 Endoscopic Outcomes With Early Treatment in Newlydiagnosed Crohn's Disease: Evidence From Profile, a Multicentre, Randomized, Open-label, Biomarker-stratified Clinical Trial
2024 · Nurulamin Noor, James Lee, et al. · Gastroenterology
IDDF2020-ABS-0183 PROFILE trial: predicting outcomes for Crohn’s disease using a molecular biomarker
2020 · Nurulamin Noor, Biljana Brezina, et al. · Gut
PDF
Works count: 8
Citation count: 1,278
H-index: 3
I10-index: 3
Year
Topic
Type